Sign Out
Hypersensitivity to escitalopram or to any of the excipients.
Concomitant treatment with non-selective, monoamine oxidase inhibitors (MAO- inhibitors) is contraindicated due to the risk of serotonin syndrome with agitation, tremor, hyperthermia etc.
The combination of escitalopram with reversible MAO-A inhibitors (e.g. moclobemide) or the reversible non-selective MAO-inhibitor linezolid is contraindicated due to the risk of onset of a serotonin syndrome.
